These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34818560)

  • 1. Environmental factors modulating protein conformations and their role in protein aggregation diseases.
    Devi S; Chaturvedi M; Fatima S; Priya S
    Toxicology; 2022 Jan; 465():153049. PubMed ID: 34818560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease.
    Hipp MS; Hartl FU
    J Mol Biol; 2024 Jul; 436(14):168615. PubMed ID: 38759929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling protein aggregation as an ageing related process or a neuropathological response.
    Trigo D; Nadais A; da Cruz E Silva OAB
    Ageing Res Rev; 2019 May; 51():67-77. PubMed ID: 30763619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
    Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteostasis and Proteotoxicity in the Network Medicine Era.
    Lualdi M; Alberio T; Fasano M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
    Lindquist SL; Kelly JW
    Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
    Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
    EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors.
    Wang S; Zheng J; Ma L; Petersen RB; Xu L; Huang K
    Biochim Biophys Acta Gen Subj; 2022 Feb; 1866(2):130061. PubMed ID: 34822925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanochaperone-Based Strategies to Control Protein Aggregation Linked to Conformational Diseases.
    Caballero AB; Gamez P
    Angew Chem Int Ed Engl; 2021 Jan; 60(1):41-52. PubMed ID: 32706460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER chaperone-metal interactions: links to protein folding disorders.
    Tiffany-Castiglioni E; Qian Y
    Neurotoxicology; 2012 Jun; 33(3):545-57. PubMed ID: 22370090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.